Raj Chopra

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)

Anthony H. Goldstone, Susan Richards, Hillard M. Lazarus et al. · Blood · 2007 · 782 citations · Full text

Medicine, Hematology, Oncology +16

Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).

Richard E. Champlin, Norbert Schmitz, Mary M. Horowitz et al. · PubMed · 2000 · 508 citations

Medicine, Cell Biology, Hematology +14

A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy

Steven Knapper, Alan K. Burnett, Tim Littlewood et al. · Blood · 2006 · 413 citations · Full text

Medicine, Oncology, Pharmacology +10

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

Suparno Chakrabarti, Stephen Mackinnon, Raj Chopra et al. · Blood · 2002 · 359 citations · Full text

Life Sciences, Hematology, Immunology +17

Phase III Randomized Multicenter Study of a Humanized Anti-CD33 Monoclonal Antibody, Lintuzumab, in Combination With Chemotherapy, Versus Chemotherapy Alone in Patients With Refractory or First-Relapsed Acute Myeloid Leukemia

Eric J. Feldman, Joseph Brandwein, Richard M. Stone et al. · Journal of Clinical Oncology · 2005 · 249 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17